CollPlant Biotechnologies Ltd Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
CollPlant Biotechnologies Ltd (CLGN) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $0.00 per share as of 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2024-04-04
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $0.00.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $0.00.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2023-12-31 | $0.00 20-F · filed 2024-04-04 |
| 2022-12-31 | $0.00 20-F · filed 2024-04-04 |
| 2021-12-31 | $0.00 20-F · filed 2024-04-04 |